Bisphenol A (BPA) is widely used in plastics, but concerns about its safety have led to the use of alternative compounds. However, some BPA substitutes may also pose health risks.
This study focuses on how BPA analogs are processed inside the body. When certain chemicals are metabolized, they can form reactive intermediates—temporary chemical species that can bind strongly to proteins. If such binding occurs, it may interfere with normal biological functions and contribute to toxicity.
Using advanced liquid chromatography–mass spectrometry (LC–MS), the researchers identified covalently active metabolites of BPA analogs. They discovered characteristic “diagnostic ions”—specific mass signals that act like fingerprints for these reactive metabolites. These signals allow scientists to detect and monitor protein-binding events more accurately.
By mapping how these metabolites interact with proteins, the study provides insight into possible mechanisms of toxicity. Rather than simply measuring BPA levels, the research examines how chemical transformation inside the body creates new reactive species.
This approach helps explain why some BPA substitutes may still pose risks, even if they appear safer in traditional exposure tests. Understanding the formation of reactive metabolites is crucial for evaluating chemical safety and designing safer materials in the future.
The study demonstrates how carefully designed mass spectrometry workflows can reveal not just what chemicals are present, but how they behave and interact inside living systems.
Reference
Q. He et al., “Covalently active metabolites of bisphenol A analogs by mass spectrometry diagnostic ions: Possible mechanisms of their toxicity,” Chemical Research in Toxicology, vol. 39, pp. 157–167, 2026, doi: 10.1021/acs.chemrestox.5c00417.
